Oculus Innovative Sciences Inc (NASDAQ:OCLS)

CAPS Rating: 1 out of 5

The Company has developed and it manufactures and markets, a family of products intended to prevent and treat infections in chronic and acute wounds.


Player Avatar HGPD99 (< 20) Submitted: 9/20/2010 11:43:45 AM : Outperform Start Price: $10.64 OCLS Score: -165.53

Amazing new products in the medical field.

Member Avatar pphill (< 20) Submitted: 10/1/2010 12:44:25 PM
Recs: 0

Agree! Efficacy of Microcyn appears to be amazing. With August 2010 approval of dermatology gel in Mexico and the beginning of sale of that product there in Sept 10 as well as in USA, the potential in that $3.2 billion mkt should kick the stock price up significantly. Looking at its over all potential in the medical industry, I see nothing but good things for OCLS, its customers and shareholders.

Featured Broker Partners